Skip to main content
In stock|Targeted Therapy (Investigational Antibody)

Omburtamab

Oncology TypeSolid Tumour (Neuroblastoma)
Drug Class / MechanismRadiolabelled Anti-B7-H3 Monoclonal Antibody (I-131)
No Image
Description

Omburtamab is classified as a Radiolabelled Anti-B7-H3 Monoclonal Antibody (I-131), sourced for use within our Targeted Therapy (Investigational Antibody) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryTargeted Therapy (Investigational Antibody)
Oncology TypeSolid Tumour (Neuroblastoma)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3